Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
55%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
36%
ALSO IN HRTS
HRTS
43
HOLDINGS
50%
ALSO IN XLV
SECTOR DRIFT (XLV minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.2% | 11.5% | 11.5% |
|
UNITEDHEALTH GROUP INC | 6.6% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 5.2% | 3.9% | 3.9% |
|
JOHNSON & JOHNSON | 10.6% | 3.9% | 3.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% | 4.3% | 3.4% |
XLV Overweight Relative to HRTS
|
JOHNSON & JOHNSON | 6.7% |
|
ABBVIE INC | 4.9% |
|
ELI LILLY & CO | 4.6% |
|
PFIZER INC | 2.4% |
|
CVS CAREMARK CORP | 2.3% |
|
ELEVANCE HEALTH INC | 1.6% |
|
AMGEN INC | 1.4% |
|
STRYKER CORP | 1.4% |
|
CIGNA CORPORATION | 1.3% |
|
MERCK & CO. INC. | 1.3% |
XLV Underweight Relative to HRTS
 |
NOVO NORDISK A/S-B | -5.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
REVOLUTION MEDICINES, INC. | -3.4% |
|
CYTOKINETICS INC | -3.4% |
 |
ASTRAZENECA PLC | -3.4% |
|
NOVARTIS AG | -3.2% |
|
BRIDGEBIO PHARMA, INC. | -2.8% |
 |
TEVA PHARMACEUTICAL-SP ADR | -1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.5% |
|
DEXCOM INC | -1.4% |